Time to Risk Stratify Methotrexate Lab Monitoring? A longitudinal cohort analysis has developed a prognostic model that informs a risk stratified approach to monitoring blood tests during long term methotrexate (MTX) therapy. https://t.co/R2TOzSO6cx https://t.co/XY3XEkSCT6
Links:
Time to Risk Stratify Methotrexate Lab Monitoring? | RheumNow
https://bit.ly/48sjR1i
Dec-28-2023


